Literature DB >> 20011552

Prenatal diagnosis for paediatricians.

Anne Summers1.   

Abstract

In Ontario, approximately 140,000 women deliver newborn infants each year. Of these women, 60,000 to 70,000 have multiple marker screening, 10,000 undergo amniocentesis or chorion villus sampling and virtually all have at least one prenatal ultrasound. Multiple marker screening is not used in every province and territory; however, amniocentesis and prenatal ultrasound are used throughout Canada. Most paediatric patients will have been exposed to some form of prenatal diagnosis. If an abnormality is found prenatally, parents may have concerns to discuss with the paediatrician after the child is born. Likewise, if a child with a problem is born following a normal pregnancy, the parents will want to know why the problem was missed prenatally. Paediatricians should be aware of prenatal tests that have been performed to understand better their patients and their families.

Entities:  

Keywords:  Amniocentesis; Multiple marker screening; Prenatal diagnosis; Prenatal ultrasound

Year:  2003        PMID: 20011552      PMCID: PMC2791073          DOI: 10.1093/pch/8.1.25

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  51 in total

1.  Fetal pyelectasis: a possible association with Down syndrome.

Authors:  B R Benacerraf; J Mandell; J A Estroff; B L Harlow; F D Frigoletto
Journal:  Obstet Gynecol       Date:  1990-07       Impact factor: 7.661

2.  Randomised controlled trial of genetic amniocentesis in 4606 low-risk women.

Authors:  A Tabor; J Philip; M Madsen; J Bang; E B Obel; B Nørgaard-Pedersen
Journal:  Lancet       Date:  1986-06-07       Impact factor: 79.321

3.  Club foot, an adverse outcome of early amniocentesis: disruption or deformation? CEMAT. Canadian Early and Mid-Trimester Amniocentesis Trial.

Authors:  S A Farrell; A M Summers; L Dallaire; J Singer; J A Johnson; R D Wilson
Journal:  J Med Genet       Date:  1999-11       Impact factor: 6.318

4.  Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening.

Authors:  M van Rijn; Y T van der Schouw; A M Hagenaars; G H Visser; G C Christiaens
Journal:  Obstet Gynecol       Date:  1999-12       Impact factor: 7.661

5.  Perinatal outcomes in a prospective matched pair study of pregnancy and unexplained elevated or low AFP screening.

Authors:  S Cho; K K Durfee; B A Keel; L H Parks
Journal:  J Perinat Med       Date:  1997       Impact factor: 1.901

6.  Significance of an echogenic intracardiac focus in fetuses at high and low risk for aneuploidy.

Authors:  B Bromley; E Lieberman; T D Shipp; M Richardson; B R Benacerraf
Journal:  J Ultrasound Med       Date:  1998-02       Impact factor: 2.153

7.  Amniotic fluid acetylcholinesterase in the prenatal diagnosis of open neural tube defects and abdominal wall defects: a comparison of gel electrophoresis and a monoclonal antibody immunoassay.

Authors:  A G Rasmussen Loft; K Nanchahal; H S Cuckle; N J Wald; M Hulten; P Leedham; B Nørgaard-Pedersen
Journal:  Prenat Diagn       Date:  1990-07       Impact factor: 3.050

8.  Hypoplasia of the middle phalanx of the fifth digit. A feature of the second trimester fetus with Down's syndrome.

Authors:  B R Benacerraf; B L Harlow; F D Frigoletto
Journal:  J Ultrasound Med       Date:  1990-07       Impact factor: 2.153

9.  Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy.

Authors:  K H Nicolaides; G Azar; D Byrne; C Mansur; K Marks
Journal:  BMJ       Date:  1992-04-04

Review 10.  The use of folic acid for the prevention of neural tube defects and other congenital anomalies.

Authors:  R Douglas Wilson; Gregory Davies; Valérie Désilets; Gregory J Reid; Anne Summers; Philip Wyatt; David Young
Journal:  J Obstet Gynaecol Can       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.